PharmStars runs a 10-week PharmaU curriculum in Boston for healthtech and biotech companies, with the Fall 2026 cohort starting 9 September 2026. Investment is $100,000 on an uncapped SAFE, with up to $500,000 available in follow-on; instead of a fixed equity percentage the SAFE carries a discount to the next round, 20% within a year and 30% after two.
This programme has notes explaining its undisclosed figures, available in the full dataset.
Every figure above is taken from these pages, published by the programme or its parent organisation.
Last verified 2026-09-07.